Helmholtz Health Partnering Event 2026

19 Nov 2026 | Berlin, Germany

Register
Register
Register

Companies

Max Delbrück Center for Molecular Medicine

University / Research Organisation

Berlin, Germany

  • Other
  • Cancer
  • Diagnostics
  • Gene Therapy
  • Cell Therapy
  • Drug Screening
  • Bioengineering
  • Early Detection
  • Metabolic Diseases
  • Biomarker Discovery
  • Infectious Diseases
  • Drug Target Discovery
  • Neurological Diseases
  • Cardiovascular Diseases
  • (Single-cell) multi-omics
  • Personalized disease models
  • Inflammation / Autoimmune Diseases
  • Data science, AI / Machine learning

Discovery for tomorrow's medicine

Berlin Partner für Wirtschaft und Technologie GmbH

Other

Berlin, Germany

  • Other
  • Other
  • Other

Berlin Partner supports innovative companies and startups in growing their business in Berlin and successfully turning their ideas into reality.

Treamid Therapeutics GmbH

Therapeutics & Diagnostics

Berlin, Germany

  • Inflammation / Autoimmune Diseases

Biotech company developing small molecules in areas of high unmet need with a focus on fibrosis.

emp BIOTECH GmbH

Other

Berlin, Germany

  • Other
  • Other
  • Bioengineering

Tame-Care

Healthcare Solutions Provider

Saint Philbert de Bouaine, France

  • Other
  • Cancer
  • Diagnostics
  • Drug Screening
  • Bioengineering
  • Early Detection
  • Metabolic Diseases
  • Therapy Monitoring
  • Infectious Diseases
  • Neurological Diseases
  • Cardiovascular Diseases
  • Inflammation / Autoimmune Diseases

Tame-Care specializes in the design, industrialization, and manufacturing of active medical devices on behalf of third parties.

Metastrict

Therapeutics & Diagnostics

Berlin, Germany

  • Cancer
  • Drug Screening
  • Early Detection
  • Biomarker Discovery
  • Drug Target Discovery
  • Clinical Research, Trials

Metastrict is a planned biotech startup developing first-in-class therapies targeting the metastasis drivers S100A4 and MACC1, combined with a blood-based companion diagnostic for patients with metastatic cancer or at high risk of developing metastases.

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)

University / Research Organisation

Berlin, Germany

  • Cancer
  • Drug Screening
  • Metabolic Diseases
  • Drug Target Discovery
  • Neurological Diseases
  • Cardiovascular Diseases

Fundamental research and scientific training in the field of molecular pharmacology.

Absea Biotechnology GmbH

Other

Berlin, Germany

  • Other
  • Other
  • Other
  • Cancer
  • Diagnostics
  • Drug Screening
  • Metabolic Diseases
  • Biomarker Discovery
  • Drug Target Discovery
  • Neurological Diseases
  • (Single-cell) multi-omics
  • Inflammation / Autoimmune Diseases

Colville Capital

Other

Berlin, Germany

  • Bioengineering
  • Cardiovascular Diseases
  • (Single-cell) multi-omics
  • Personalized disease models
  • Data science, AI / Machine learning

Investment firm that invests in early stage ventures.

Illumina GmbH

Healthcare Solutions Provider

Berlin, Germany

  • Cancer
  • Therapy Monitoring
  • Biomarker Discovery
  • Infectious Diseases
  • Neurological Diseases
  • (Single-cell) multi-omics
  • Inflammation / Autoimmune Diseases

EPO GmbH

Other

Berlin, Germany

  • Other
  • Other
  • Other
  • Cancer
  • Diagnostics
  • Gene Therapy
  • Cell Therapy
  • Drug Screening
  • Early Detection
  • RNA-based Therapy
  • Therapy Monitoring
  • Biomarker Discovery
  • Drug Target Discovery
  • (Single-cell) multi-omics
  • Personalized disease models
  • Data science, AI / Machine learning

Biosynth GmbH

Drug manufacturer

Berlin, Germany

  • Other
  • Other
  • Cancer
  • Infectious Diseases
  • Inflammation / Autoimmune Diseases

Biosynth GmbH is a contract development and manufacturing organization for bioconjugate drugs and functionalized polymers.

EBViously

Other

Munich, Germany

  • Other
  • Other
  • Infectious Diseases
  • Neurological Diseases
  • Clinical Research, Trials
  • Inflammation / Autoimmune Diseases

We are developing a next-generation virus-like particle vaccine to prevent EBV-associated disease and long term sequelae such as chronic fatigue and multiple sclerosis.

Helmholtz Munich

University / Research Organisation

Oberschleissheim, Germany

  • Cancer
  • Metabolic Diseases
  • Neurological Diseases
  • Cardiovascular Diseases
  • Inflammation / Autoimmune Diseases

NovInCell Therapeutics

Therapeutics & Diagnostics

Berlin, Germany

  • Drug Target Discovery
  • Neurological Diseases
  • Cardiovascular Diseases

NovInCell Therapeutics develops novel vascular-protective therapies for acute ischemic stroke, targeting PI3KC2β to preserve blood-brain barrier integrity and complement current reperfusion treatments.

CheckImmune GmbH

Diagnostics/Laboratory

Berlin, Germany

  • Other
  • Other
  • Other
  • Cancer
  • Diagnostics
  • Gene Therapy
  • Cell Therapy
  • Liquid Biopsy
  • Early Detection
  • RNA-based Therapy
  • Metabolic Diseases
  • Therapy Monitoring
  • Biomarker Discovery
  • Infectious Diseases
  • Drug Target Discovery
  • Cardiovascular Diseases
  • (Single-cell) multi-omics
  • Clinical Research, Trials
  • Inflammation / Autoimmune Diseases
  • Data science, AI / Machine learning

CheckImmune offers lab services, data interpretation & consulting for immune biomarkers. Innovative and science-driven.

Parse Biosciences

Other

Germany, Germany

  • Cancer
  • Diagnostics
  • Cell Therapy
  • Drug Screening
  • RNA-based Therapy
  • Metabolic Diseases
  • Biomarker Discovery
  • Infectious Diseases
  • Drug Target Discovery
  • Neurological Diseases
  • Cardiovascular Diseases
  • (Single-cell) multi-omics
  • Inflammation / Autoimmune Diseases

Single-cell RNA sequencing

Nuvisan ICB GmbH

Therapeutics & Diagnostics

Berlin, Germany

  • Other
  • Cancer
  • Gene Therapy
  • Cell Therapy
  • Drug Screening
  • RNA-based Therapy
  • Metabolic Diseases
  • Biomarker Discovery
  • Drug Target Discovery
  • Neurological Diseases
  • Cardiovascular Diseases
  • Clinical Research, Trials
  • Inflammation / Autoimmune Diseases

Integrated CRO supporting pharma & biotech from target to patient with discovery, development & clinical services.

JUNI

Other

Berlin, Germany

  • Other
  • Other
  • Other

Mit UNITE betreiben Partner aus Wissenschaft, Wirtschaft und Gesellschaft ein international führendes Innovations- und Gründungszentrum.

Sino Biological Europe GmbH

Other

Eschborn, Germany

  • Cancer
  • Diagnostics
  • Cell Therapy
  • Drug Screening
  • Bioengineering
  • Metabolic Diseases
  • Infectious Diseases
  • Drug Target Discovery
  • Neurological Diseases
  • Cardiovascular Diseases
  • Inflammation / Autoimmune Diseases
  • Data science, AI / Machine learning

Pure and reliable solutions, from our experts, to You!

69 results

Organisation Types

Countries

Areas of Activity

Disease Area

Biomedical Research, Medicine, Human Health

Technology